Guaifenesin
NDC 83720-503, Guaifenesin, liquid, from Oncor Pharmaceuticals.
- Product NDC
- 83720-503
- Status
- Listed
- Labeler
- Oncor Pharmaceuticals
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83720-503 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN100 mg/5mL
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83720-503-16 | 83720050316 | 473 mL in 1 BOTTLE (83720-503-16) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 83720050316
GET /v1/drugs/nadac/83720050316
Use it
Look up 83720-503 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83720-503 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83720-503. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.